Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

Overactivation of mineralocorticoid receptor pathways has been implicated in the pathophysiology of central serous chorioretinopathy (CSCR). Recently, mineralocorticoid receptor antagonists such as eplerenone have demonstrated success in treating subretinal fluid in CSCR. This case demonstrates a pa...

Full description

Bibliographic Details
Main Authors: Kapil G. Kapoor, Alan L. Wagner
Format: Article
Language:English
Published: Karger Publishers 2015-12-01
Series:Case Reports in Ophthalmology
Subjects:
Eplerenone
Mineralocorticoid antagonist
Polypoidal choroidal vasculopathy
Online Access:http://www.karger.com/Article/FullText/442661

Internet

http://www.karger.com/Article/FullText/442661

Similar Items